1a2y:B (VAL2) to (VAL114) HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3 | COMPLEX (IMMUNOGLOBULIN/HYDROLASE), IMMUNOGLOBULIN V REGION, SIGNAL, HYDROLASE, GLYCOSIDASE, BACTERIOLYTIC ENZYME, EGG WHITE
2ajz:B (GLU1) to (VAL111) CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER | CATALYTIC ANTIBODY, FAB, ECGONINE METHYL ESTER, HYDROLYTIC, IMMUNE SYSTEM
1a7q:H (VAL202) to (VAL314) FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY, ILE29L->THR, GLU81L->ASP, THR97L->SER, PRO240H->LEU, ASP258H->ALA, LYS281H->GLU, ASN283H->ASP AND LEU312H->VAL | IMMUNOGLOBULIN, VARIANT
3eba:A (GLN1) to (SER120) CABHUL6 FGLW MUTANT (HUMANIZED) IN COMPLEX WITH HUMAN LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, IMMUNOGLOBULIN, NANOBODY, HUMANIZATION, AMYLOID FIBRIL FORMATION INHIBITION, AMYLOID, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, DISEASE MUTATION, GLYCOSIDASE, HYDROLASE, POLYMORPHISM, IMMUNE SYSTEM/HYDROLASE COMPLEX
4why:I (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4why:K (VAL2) to (SER111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM | NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN
4gxu:W (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ai1:H (GLN1) to (VAL111) HIV-1 V3 LOOP MIMIC | COMPLEX (ANTIBODY/PEPTIDE), ANTIBODY, CONSTRAINED HIV-1 V3 LOOP PEPTIDE, IMMUNOGLOBULIN
2oqj:K (GLN3) to (GLY104) CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2orb:H (VAL2) to (SER112) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, LONG CDR H3, IMMUNE SYSTEM
2orb:I (VAL2) to (SER112) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, LONG CDR H3, IMMUNE SYSTEM
2otu:D (VAL2) to (SER117) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM
2otw:B (VAL2) to (VAL116) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY, POLYGLUTAMINE, COMPLEX, IMMUNE SYSTEM
2otw:D (VAL2) to (SER117) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY, POLYGLUTAMINE, COMPLEX, IMMUNE SYSTEM
3eot:H (GLN3) to (VAL116) CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB | ANTIBODY, FAB, VLA-1, DOMAIN SWAP, PROTEN ENGINEERING, IMMUNE SYSTEM
1axt:H (GLU1) to (SER112) IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES | IMMUNOGLOBULIN, ANTIBODY FAB', CATALYST, ALDOLASE REACTION
4wv1:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3 | FGFR2, FAB, COMPLEX, ANTIBODY, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4wv1:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3 | FGFR2, FAB, COMPLEX, ANTIBODY, TRANSFERASE-IMMUNE SYSTEM COMPLEX
2p8l:B (ARG1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN | NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN
2p8m:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM | NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN
2p8p:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC] | NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN
1baf:H (VAL2) to (VAL113) 2.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN | IMMUNOGLOBULIN, IMMUNE SYSTEM
4hh9:B (VAL2) to (VAL111) ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 | FAB, ANTIBODY, IMMUNE SYSTEM
4hh9:D (VAL2) to (VAL111) ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 | FAB, ANTIBODY, IMMUNE SYSTEM
4hha:B (VAL2) to (VAL111) ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 WITH EPITOPE PEPTIDE AD-2S1 | FAB FRAGMENT, ANTIBODY, IMMUNE SYSTEM
3s36:H (GLN3) to (SER115) STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES | ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX
4hjg:B (VAL2) to (VAL118) MEDITOPE-ENABLED TRASTUZUMAB | MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC
1bfv:H (VAL2) to (VAL117) MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI | IMMUNOGLOBULIN, FV FRAGMENT, STEROID HORMONE, FINE SPECIFICITY
4hkz:B (VAL2) to (SER119) TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS | MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC
2pcp:B (VAL2) to (VAL111) ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE | IMMUNOGLOBULIN
4hlz:G (LYS3) to (SER112) CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H2N2 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2bmk:B (VAL2) to (SER112) FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE | CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM
1bln:B (VAL2) to (SER112) ANTI-P-GLYCOPROTEIN FAB MRK-16 | IMMUNOGLOBULIN, IMMUNE SYSTEM
4x4y:A (GLN3) to (SER119) RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT K30D/S52D. | ANTIBODY STABILIZATION MUTATIONS, IMMUNE SYSTEM
4x4y:C (GLN3) to (SER119) RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT K30D/S52D. | ANTIBODY STABILIZATION MUTATIONS, IMMUNE SYSTEM
3s88:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN GULU) BOUND TO 16F6 | GLYCOSYLATION, VIRAL MEMBRANE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4x7t:H (GLN3) to (VAL119) STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2 | ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM
1bvk:B (VAL2) to (VAL114) HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME | HUMANIZED ANTIBODY, ANTIBODY COMPLEX, FV, ANTI-LYSOZYME, COMPLEX (HUMANIZED ANTIBODY/HYDROLASE)
4hs8:H (VAL2) to (VAL111) HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3 | IMMUNE SYSTEM
4xbg:C (GLN1) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4hxa:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF 13D9 FAB | ANTIBODY, FAB, IMMUNE SYSTEM, CARBOHYDRATE, COMPLEMENTARITY DETERMINING REGIONS
4i18:H (VAL5) to (VAL126) CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT | IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN
4i18:A (VAL5) to (VAL126) CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT | IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN
4xgz:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:E (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:G (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:J (ILE-1) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:M (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:O (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:Q (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:S (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:U (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xgz:W (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
3sgd:H (VAL2) to (SER114) CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2 | IMMUNOGLOBULIN FOLD, ANTIBODY, ANTIGEN BINDING, IMMUNE SYSTEM
3sgd:J (VAL2) to (SER114) CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2 | IMMUNOGLOBULIN FOLD, ANTIBODY, ANTIGEN BINDING, IMMUNE SYSTEM
2pr4:H (ARG1) to (SER131) CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 | NMAB 2F5, GP41, HIV, VIRAL PROTEIN
1om3:H (GLN3) to (SER112) FAB 2G12 UNLIGANDED | FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM
3skj:L (ASP1) to (ILE106) STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY | FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM
3skj:I (VAL2) to (SER112) STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY | FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM
1cfv:H (VAL2) to (SER119) MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI | FV FRAGMENT, STEROID HORMONE, FINE SPECIFICITY, IMMUNOGLOBULIN
2pw1:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL | HIV-1, 2F5, GP41, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
2pw2:B (ARG1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL | HIV-1, GP41, 2F5, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
3fo1:H (VAL2) to (VAL119) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1op3:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN | DOMAIN-SWAPPED FAB 2G12; ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1op5:M (GLN3) to (SER112) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2 | DOMAIN-SWAPPED FAB 2G12 MAN9GLCNAC2 ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1ors:B (VAL2) to (SER117) X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB | POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, VOLTAGE SENSOR, KVAP, FAB COMPLEX, MEMBRANE PROTEIN
1cly:H (ASN3) to (SER112) IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER | IMMUNOGLOBULIN, IMMUNOGLOBULIN C REGION, GLYCOPROTEIN, ANTIB
1clz:H (ASN3) to (VAL111) IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER | IMMUNOGLOBULIN C REGION, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN
3stb:B (GLN5) to (SER128) A COMPLEX OF TWO EDITOSOME PROTEINS AND TWO NANOBODIES | RNA EDITING, EDITOSOME, NANOBODY, SINGLE DOMAIN ANTIBODY, VHH, KREPA3, KREPA6, RNA BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
3fzu:H (GLN3) to (VAL116) IGG1 FAB CHARACTERIZED BY H/D EXCHANGE | IGG1 FAB, IMMUNE SYSTEM
4xp1:H (VAL2) to (VAL117) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO NEUROTRANSMITTER DOPAMINE | INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX
4xp4:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH COCAINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, MEMBRANE PROTEIN-TRANPORT PROTEIN COMPLEX, TRANSPORT PROTEIN- INHIBITOR COMPLEX
4xpt:H (VAL2) to (SER118) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS D121G/S426M AND EL2 DELETION OF 162-201 IN COMPLEX WITH SUBSTRATE ANALOGUE 3,4 DICHLOROPHEN ETHYLAMINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX, PROTEIN TRANSPORT-INHIBITOR COMPLEX
4ij3:C (VAL2) to (VAL116) OXIDOREDUCTASE FRAGMENT OF HUMAN QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTI- HUMAN QSOX1 ANTIBODY | INHIBITOR, ANTIBODY BINDING, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX
3g5z:B (ASP1) to (THR113) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
2qhr:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE. | IMMUNOLOGLOBULIN FOLD, ANTIBODY-PEPTIDE COMPLEX, IMMUNE SYSTEM/VIRAL PROTEIN COMPLEX
4iof:C (GLN3) to (SER128) CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) | HYDROLASE, ZINC METALLOPROTEASE
4iof:E (GLN3) to (SER128) CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) | HYDROLASE, ZINC METALLOPROTEASE
4ioi:B (VAL2) to (VAL118) MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC | MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER IMMUNOTHERAPY
4xwo:C (GLN6) to (SER121) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:I (SER3) to (SER121) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
2qqk:H (VAL2) to (VAL111) NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
2qr0:B (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:F (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:H (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:L (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:N (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:R (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:T (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:X (GLN3) to (SER112) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
4xxd:B (VAL2) to (VAL106) CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB | FAB, AMYLOID-BETA, IMMUNE SYSTEM
4xxd:E (VAL2) to (SER107) CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB | FAB, AMYLOID-BETA, IMMUNE SYSTEM
3ggw:D (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE | PEPTIDE-CARBOHYDRATE MIMICRY, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM
1dvf:B (VAL2) to (VAL114) IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX | COMPLEX (IDIOTOPE-ANTIIDIOTOPE), IMMUNOGLOBULIN
2r0l:H (GLN3) to (SER112) SHORT FORM HGFA WITH INHIBITORY FAB75 | SERINE PROTEASE, ANTIBODY, ALLOSTERIC INHIBITOR, EGF-LIKE DOMAIN, GLYCOPROTEIN, HYDROLASE, KRINGLE, SECRETED, ZYMOGEN, IMMUNE SYSTEM
2r1x:B (VAL2) to (VAL109) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
2r2b:B (VAL2) to (VAL109) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
2r2e:B (VAL2) to (SER110) CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
2r2h:B (VAL2) to (VAL109) STRUCTURE OF S25-2 IN COMPLEX WITH KO | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
4y5y:A (VAL2) to (SER117) DIABODY 330 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4y5y:D (VAL2) to (SER117) DIABODY 330 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
2r56:H (SER3) to (SER120) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
2r56:I (SER3) to (SER120) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
4jam:H (GLN1) to (SER110) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103 | NEUTRALIZATION, VACCINE, HIV-1, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
1q9l:D (LYS3) to (VAL109) S25-2 FAB UNLIGANDED 2 | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
1q9o:D (VAL2) to (VAL109) S45-18 FAB UNLIGANDED | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
1q9w:B (VAL2) to (VAL109) S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CABOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, PROTEIN-CARBOHYDRATE COMPLEX, IMMUNE SYSTEM
1q9w:D (VAL2) to (SER110) S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CABOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, PROTEIN-CARBOHYDRATE COMPLEX, IMMUNE SYSTEM
3tnm:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
3tnn:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
3tnn:C (VAL2) to (VAL111) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
3tnn:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY. | ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM
4jfy:B (VAL2) to (SER112) APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
2dtm:H (LYS3) to (SER112) THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
1qkz:H (VAL2) to (VAL111) FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G | IMMUNE SYSTEM, FAB, PORA, NEISSERIA MENINGITIDIS, PORIN
4jlr:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB | ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM
4jlr:A (VAL2) to (VAL111) CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB | ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM
4jlr:B (ASP1) to (THR109) CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB | ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM
4jm2:A (GLN1) to (THR110) CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1ezv:X (GLU1) to (THR119) STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO- CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT | CYTOCHROME BC1 COMPLEX, COMPLEX III, QCR, MITOCHONDRIA, YEAST, ANTIBODY FV-FRAGMENT, STIGMATELLIN, COENZYME Q6, MATRIX PROCESSING PEPTIDASES, UBIQUINONE, ELECTRON TRANSFER, PROTON TRANSFER, Q-CYCLE, OXIDOREDUCTASE/ELECTRON TRANSPORT COMPLEX
4jqi:H (GLN6) to (SER122) STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE | ARRESTIN, GPCR, G-PROTEIN COUPLED RECEPTOR, SIGNALING, SIGNALING PROTEIN
1f4x:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1f4y:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN | ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
3u4e:H (PCA2) to (VAL111) CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
3u6r:H (VAL4) to (SER128) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 SINGLE CHAIN FV FRAGMENT 1:7 | IG-LIKE DOMAIN, NEUTRALIZING SINGLE CHAIN FV, IMMUNE SYSTEM
3u6r:A (VAL4) to (SER128) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 SINGLE CHAIN FV FRAGMENT 1:7 | IG-LIKE DOMAIN, NEUTRALIZING SINGLE CHAIN FV, IMMUNE SYSTEM
2uzi:H (VAL2) to (SER114) CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV COMPLEX | SIGNAL TRANSDUCTION, IMMUNOGLOBULIN DOMAIN, MEMBRANE, ANTIBODY, ONCOGENE, PALMITATE, INTRABODY, DISEASE MUTATION, NUCLEOTIDE-BINDING, PROTO-ONCOGENE, CANCER THERAPY, GOLGI APPARATUS, PRENYLATION, METHYLATION, LIPOPROTEIN, GTP- BINDING, SIGNALING PROTEIN/IMMUNE SYSTEM
1fgv:H (VAL2) to (VAL122) X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65 | IMMUNOGLOBULIN, IMMUNE SYSTEM
3hi6:H (GLN3) to (SER119) CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57 | INTEGRIN, I DOMAIN, FAB, LIGAND MIMETIC ANTIBODY, CELL ADHESION, ALTERNATIVE SPLICING, CALCIUM, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, CELL ADHESION/IMMUNE SYSTEM COMPLEX
1fl6:H (VAL2) to (VAL111) THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
1fl6:B (VAL2) to (VAL111) THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
1frg:H (VAL219) to (SER336) CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY | IMMUNOGLOBULIN/VIRUS HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4k7p:Y (VAL2) to (SER112) GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG | IMMUNOGLOBULIN, IMMUNE SYSTEM
1fvc:D (GLN3) to (VAL118) X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING | IMMUNOGLOBULIN
2f5b:H (ARG1) to (SER131) CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41, IMMUNOGLOBULIN
2f5a:H (ARG1) to (SER131) CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 | FAB, HIV-1 NEUTRALIZATION, GP41, IMMUNOGLOBULIN
2fbj:H (VAL2) to (VAL116) REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
1rvf:H (GLN1) to (VAL111) FAB COMPLEXED WITH INTACT HUMAN RHINOVIRUS | POLYPROTEIN, COAT PROTEIN, CORE PROTEIN, RNA-DIRECTED RNA POLYMERASE, HYDROLASE, THIOL PROTEASE, MYRISTYLATION, COMPLEX (COAT PROTEIN/IMMUNOGLOBULIN), ICOSAHEDRAL VIRUS, VIRUS/IMMUNE SYSTEM COMPLEX
1g7i:B (VAL2) to (VAL114) CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F) | HYDROLASE INHIBITOR/HYDROLASE
4z5r:K (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:M (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:W (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:Q (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:S (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:U (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:Z (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
4z5r:B (VAL2) to (VAL111) RONTALIZUMAB FAB BOUND TO INTERFERON-A2 | ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX
1g9m:H (GLN1) to (THR127) HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120 FROM LABORATORY-ADAPTED ISOLATE, HXBC2, SURFACE T-CELL GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2fjf:H (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:D (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:F (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:K (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:N (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjf:R (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
2fjg:H (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | PROTEIN FAB COMPLEX, FAB, VEGF, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
2fjg:B (GLN3) to (SER119) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | PROTEIN FAB COMPLEX, FAB, VEGF, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
2fjh:H (GLN3) to (SER120) STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | VEGF, FAB, PROTEIN FAB COMPLEX, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
2fjh:B (GLN3) to (VAL119) STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF | VEGF, FAB, PROTEIN FAB COMPLEX, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX
3hr5:B (GLN3) to (SER116) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
3hr5:I (GLN3) to (VAL115) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
3hr5:J (VAL2) to (VAL115) M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB | FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM
4zff:A (GLN3) to (VAL111) DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF | FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4zfg:H (VAL2) to (SER112) DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2 | FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4kq4:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1shm:D (VAL2) to (SER112) CONVERGENT SOLUTIONS TO VHH DOMAIN STABILIZATION FROM NATURAL AND IN VITRO EVOLUTION | HEAVY CHAIN VARIABLE DOMAIN, VHH DOMAIN, IMMUNOGLOBULIN, IMMUNE SYSTEM
1gpo:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT | PROTEIN ENGINEERING, ANTIBODY DESIGN, IMMUNOGLOBULIN STRUCTURE, ANTIGEN-BINDING SITE, CANONICAL CONFORMATION, COMPLEMENTARITY- DETERMINING REGION, IMMUNE SYSTEM
1gpo:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT | PROTEIN ENGINEERING, ANTIBODY DESIGN, IMMUNOGLOBULIN STRUCTURE, ANTIGEN-BINDING SITE, CANONICAL CONFORMATION, COMPLEMENTARITY- DETERMINING REGION, IMMUNE SYSTEM
2g5b:B (VAL2) to (SER110) CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE. | 6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS
2g5b:D (VAL2) to (VAL109) CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE. | 6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS
2g5b:H (VAL2) to (SER110) CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE. | 6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS
2vxs:J (VAL2) to (SER112) STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY | EPITOPE, COMPLEX, ANTIBODY, SECRETED, CYTOKINE, GLYCOPROTEIN, INTERLEUKIN-17
2vxs:K (VAL2) to (SER112) STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY | EPITOPE, COMPLEX, ANTIBODY, SECRETED, CYTOKINE, GLYCOPROTEIN, INTERLEUKIN-17
2vyr:E (VAL2) to (SER123) STRUCTURE OF HUMAN MDM4 N-TERMINAL DOMAIN BOUND TO A SINGLE DOMAIN ANTIBODY | NUCLEUS, HUMAN MDM4, IMMUNE SYSTEM, ZINC-FINGER
2vyr:F (VAL2) to (SER123) STRUCTURE OF HUMAN MDM4 N-TERMINAL DOMAIN BOUND TO A SINGLE DOMAIN ANTIBODY | NUCLEUS, HUMAN MDM4, IMMUNE SYSTEM, ZINC-FINGER
2vyr:H (VAL2) to (SER123) STRUCTURE OF HUMAN MDM4 N-TERMINAL DOMAIN BOUND TO A SINGLE DOMAIN ANTIBODY | NUCLEUS, HUMAN MDM4, IMMUNE SYSTEM, ZINC-FINGER
4kzd:H (VAL5) to (SER124) CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FLUOROPHORE AND FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE BINDING, IN VITRO, IMMUNE SYSTEM-RNA COMPLEX
3idg:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD | HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM
3idj:B (ARG1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS | HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM
3idn:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS | HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM
3idy:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221 | HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
3idy:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221 | HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
3ifn:H (VAL2) to (SER119) X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX | ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM
2gsg:D (VAL2) to (SER117) CRYSTAL STRUCTURE OF THE FV FRAGMENT OF A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE | FV, MONOCLONAL ANTIBODY, POLY-GLUTAMINE, IMMUNE SYSTEM
3ijh:B (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH KO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijh:D (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH KO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijs:B (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH TSBP | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ijy:D (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
3ikc:D (VAL2) to (VAL111) STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO | ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM
1hcv:A (GLN3) to (SER112) LLAMA HEAVY CHAIN VARIABLE DOMAIN AGAINST ALPHA SUBUNIT OF HCG (HUMAN CHORIONIC GONADOTROPIN) | CAMELIDS, IMMUNOGLOBULIN
1hez:B (VAL2) to (SER120) ANTIBODY-ANTIGEN COMPLEX | ANTIBODY, SUPERANTIGEN
4lgr:B (VAL2) to (VAL117) RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH3) | RIBOSOME INHIBITING PROTEIN 2, HYDROLASE-IMMUNE SYSTEM COMPLEX
2h1p:H (VAL302) to (SER419) THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES | ANTIBODY STRUCTURE, CRYPTOCOCCUS, PEPTIDE, PHAGE LIBRARY, POLYSACCHARIDE, COMPLEX (ANTIBODY/PEPTIDE)
1tjh:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE | 2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
4zyk:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14 | IG DOMAIN, FAB, IMMUNE SYSTEM
2hff:B (GLN3) to (SER112) CRYSTAL STRUCTURE OF CB2 FAB | FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM
2hff:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF CB2 FAB | FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM
3ixt:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE | FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
3ixt:A (VAL2) to (VAL111) CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE | FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
4lly:A (VAL2) to (SER118) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A | FAB, IMMUNE SYSTEM
4lly:C (GLN3) to (SER118) CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A | FAB, IMMUNE SYSTEM
2hkf:H (GLU1) to (SER118) CRYSTAL STRUCTURE OF THE COMPLEX FAB M75- PEPTIDE | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM
1tzg:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 | ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
1tzg:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 | ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
4lqf:H (VAL2) to (VAL115) STRUCTURE OF MURINE IGG2B A2C7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.3 ANGSTROMS | IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2B, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM
4lu5:H (VAL2) to (VAL111) STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS | IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM
1u8k:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8h:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8i:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8j:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8l:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8m:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8n:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8o:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8p:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u8q:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u91:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC) | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u93:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC) | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1u95:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1ub5:H (LYS3) to (SER115) CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K | ANTIBODY FLUORSCENCE DYNAMICS, SERA LIGAND, IMMUNE SYSTEM
1ub5:A (LYS3) to (SER115) CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K | ANTIBODY FLUORSCENCE DYNAMICS, SERA LIGAND, IMMUNE SYSTEM
1ucb:H (VAL2) to (VAL111) STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ) | FAB, IMMUNOGLOBULIN, ANTIBODY, ANTI-TUMOR, CHIMERA
1igc:H (VAL2) to (VAL118) IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS | PROTEIN G, STREPTOCOCCUS, COMPLEX (ANTIBODY/BINDING PROTEIN) COMPLEX
1igf:J (VAL2) to (SER112) CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IMMUNOGLOBULIN
1igy:B (LYS3) to (VAL111) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN
1igy:D (LYS3) to (VAL111) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN
4m48:H (VAL2) to (SER118) X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM | SLC6, NEUROTRANSMITTER TRANSPORTER, TRANSPORT PROTEIN
2ibz:X (GLU1) to (THR119) YEAST CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN | MULTISUBUNIT MEMBRANE PROTEIN COMPLEX, OXIDOREDUCTASE
2x1o:B (VAL2) to (SER121) GELSOLIN NANOBODY | CONTRACTILE PROTEIN
2x1p:A (GLN3) to (SER126) GELSOLIN NANOBODY | CONTRACTILE PROTEIN
2ipu:H (VAL2) to (SER112) PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE | WWDDD, CDR, ABETA, IMMUNE SYSTEM
2ipu:G (VAL2) to (SER112) PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE | WWDDD, CDR, ABETA, IMMUNE SYSTEM
2iq9:H (VAL2) to (SER112) PFA2 FAB FRAGMENT, TRICLINIC APO FORM | PFA2, WWDDD, CDR, IMMUNE SYSTEM
3wlw:C (VAL2) to (SER116) MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER | HYDROLASE-IMMUNE SYSTEM COMPLEX
1v7m:H (VAL2) to (SER115) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
1v7n:J (VAL2) to (VAL114) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
3j42:G (VAL2) to (SER119) OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY | DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX
3j42:I (VAL2) to (SER119) OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY | DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX
3j42:K (VAL2) to (SER119) OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY | DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX
4mqt:B (GLN1) to (VAL119) STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO AND ALLOSTERIC MODULATOR LY2119620 | G PROTEIN-COUPLED RECEPTOR, MUSCARINIC ACETYLCHOLINE RECEPTOR, ALLOSTERIC MODULATION, SIGNALING PROTEIN
5aum:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE | ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX
5aum:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE | ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX
2j4w:H (VAL2) to (VAL111) STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX | IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, MEMBRANE, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, ANTIBODY CROSS- REACTIVITY, SURFACE ACTIVE PROTEIN, MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, IMMUNE SYSTEM
2j5l:C (VAL2) to (SER112) STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX | MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MEROZOITE, TRANSMEMBRANE, IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, ANTIBODY CROSS-REACTIVITY
5b3n:A (VAL4) to (VAL121) THE CRYSTAL STRUCTURE OF ANTI-H4K20ME1_SCFV, 15F11 | HISTONE MODIFICATION, SCFV, INTRABODY, IMMUNE SYSTEM
5b8c:K (VAL2) to (VAL118) HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV | ANTIBODY, IMMUNE SYSTEM
5bop:A (VAL2) to (SER124) CRYSTAL STRUCTURE OF THE ARTIFICIAL NANOBODY OCTARELLINV.1 COMPLEX | SYNTHETIC GENE, ARTIFICIAL PROTEIN, ROSSMANN-LIKE, DE NOVO PROTEIN
5bop:C (VAL2) to (SER124) CRYSTAL STRUCTURE OF THE ARTIFICIAL NANOBODY OCTARELLINV.1 COMPLEX | SYNTHETIC GENE, ARTIFICIAL PROTEIN, ROSSMANN-LIKE, DE NOVO PROTEIN
4n9g:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9 | ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM
3zhk:A (VAL2) to (VAL117) THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD | IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY
4nbx:B (GLN10) to (SER129) CRYSTAL STRUCTURE OF CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT TCDA-A1 BOUND TO A20.1 VHH | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4nc2:B (VAL2) to (SER121) CRYSTAL STRUCTURE OF TCDB-B1 BOUND TO B39 VHH | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
5bvj:B (VAL2) to (VAL116) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5bvj:H (VAL2) to (SER117) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
1kb9:J (GLU1) to (THR119) YEAST CYTOCHROME BC1 COMPLEX | OXIDOREDUCTASE, UBIQUINONE, STIGMATELLIN, CARDIOLIPIN, PHOSPHATIDYLINOSITOL, PHOSPHATIDYLCHOLIN, PHOSPHATIDYLETHANOLAMIN, UNDECYL-MALTOPYRANOSIDE,, OXIDOREDUCTASE-ELECTRON TRANSPORT COMPLEX
4nhh:H (GLN3) to (SER114) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:M (GLN3) to (SER112) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:E (GLN3) to (SER114) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:O (GLN3) to (SER112) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:R (GLN3) to (SER112) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
3zkm:H (GLN3) to (SER115) BACE2 FAB COMPLEX | HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE/FAB COMPLEX
1kc5:H (VAL2) to (SER115) CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN, COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
3zkx:C (LEU163) to (SER270) TERNARY BACE2 XAPERONE COMPLEX | HYDROLASE
4nik:B (VAL4) to (VAL117) STRUCTURE OF HUMAN GANKYRIN IN COMPLEX TO THE SINGLE CHAIN ANTIBODY F5 | BETA-HAIRPIN-ALPHA-HAIRPIN REPEAT, ONCOPROTEIN, 26S PROTEASOME, ONCOPROTEIN-IMMUNE SYSTEM COMPLEX
1kcv:H (GLN1) to (VAL114) CRYSTAL STRUCTURE OF ANTIBODY PC282 | ANTI-PEPTIDE ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
1kel:H (VAL2) to (SER118) CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID) | SULFIDE OXIDATION, MONOOXYGENASE, OXYGENATION, FAB, IMMUNOGLOBULIN, CATALYTIC ANTIBODY
1kem:H (VAL2) to (SER118) CATALYTIC ANTIBODY 28B4 FAB FRAGMENT | SULFIDE OXIDATION, MONOOXYGENASE, OXYGENATION, FAB, IMMUNOGLOBULIN, CATALYTIC ANTIBODY
1kfa:H (VAL2) to (SER120) CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4 | IMMUNOGLOBUILN FOLD, IMMUNE SYSTEM
2mcp:H (VAL2) to (VAL120) REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
4nug:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151 | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE
4nyl:E (VAL2) to (VAL119) CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT | IMMUNOGLOBULIN FOLDING, ANTIBODY FRAGMENT, TNF ALPHA, IMMUNE SYSTEM
5c8j:E (GLN6) to (SER130) A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE | MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN
1kyo:U (GLU1) to (THR119) YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C | MULTISUBUNIT MEMBRANE PROTEIN COMPLEX, ENZYME SUBSTRATE COMPLEX, ELECTRON TRANSFER COMPLEX, ANTIBODY FV FRAGMENT MEDIATED CRYSTALLIZATION, OXIDOREDUCTASE/ELECTRON TRANSPORT COMPLEX
2nr6:D (ILE2) to (VAL114) CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2 | BLA G 2, FAB, HYDROLASE-IMMUNE SYSTEM COMPLEX
4oaw:D (GLN1) to (SER112) FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4ocl:C (GLN4) to (SER122) CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM IA | 26S PROTEASOME, ISOPEPTIDASE ACTIVITY, REGULATORY PARTICLE, LID, UBIQUITIN, HYDROLASE, PROTEIN BINDING
4ocl:F (GLN4) to (SER122) CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM IA | 26S PROTEASOME, ISOPEPTIDASE ACTIVITY, REGULATORY PARTICLE, LID, UBIQUITIN, HYDROLASE, PROTEIN BINDING
4ocn:F (GLN4) to (SER122) CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM II | 26S PROTEASOME, ISOPEPTIDASE ACTIVITY, REGULATORY PARTICLE, LID, UBIQUITIN, HYDROLASE, PROTEIN BINDING
2ny0:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny4:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4odt:H (VAL2) to (SER112) FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE | CARBOHYDRATE BINDING, IMMUNE SYSTEM
2ny6:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4odv:H (VAL2) to (SER112) FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE | CARBOHYDRATE BINDING, IMMUNE SYSTEM
4odw:A (VAL2) to (SER112) UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 | CARBOHYDRATE BINDING, IMMUNE SYSTEM
2nz9:F (GLN3) to (VAL116) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
1lo3:Y (VAL2) to (SER118) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE | FAB, CATALYTIC ANTIBODY, PRODUCT COMPLEX, IMMUNE SYSTEM
5csz:H (VAL2) to (SER125) CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11 | ANTIBODY, ALZHEIMER, ABETA, GANTENERUMAB, GANT_ABETA_1_11 09-A, IMMUNE SYSTEM
5csz:A (VAL2) to (SER125) CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11 | ANTIBODY, ALZHEIMER, ABETA, GANTENERUMAB, GANT_ABETA_1_11 09-A, IMMUNE SYSTEM
2zkh:H (GLU1) to (SER115) HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT(ANTIBODY), IMMUNE SYSTEM
4oqt:H (VAL2) to (SER117) LINGO-1/LI81 FAB COMPLEX | LEUCINE RICH REPEAT, IG DOMAIN, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4orz:C (GLN5) to (SER117) HIV-1 NEF PROTEIN IN COMPLEX WITH SINGLE DOMAIN ANTIBODY SDAB19 AND AN ENGINEERED HCK SH3 DOMAIN | SH3 DOMAIN, IMMUNGLOBOLIN FOLD, ANTIBODIES, EPITOPES, HIV ANTIBODIES, HIV ACCESSORY PROTEINS, PXXP MOTIF, COMPLEMENTARITY DETERMINING REGIONS, TRANSFERASE-APOPTOSIS-IMMUNE SYSTEM COMPLEX
4ouu:H (VAL2) to (SER117) ANTI-MT1-MMP MONOCLONAL ANTIBODY | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IMMUNOGLOBULIN FOLD, HYDROLASE
4ouu:B (VAL2) to (SER117) ANTI-MT1-MMP MONOCLONAL ANTIBODY | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IMMUNOGLOBULIN FOLD, HYDROLASE
1y0l:B (VAL2) to (VAL111) CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM
1mcp:H (VAL2) to (VAL120) PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS | IMMUNOGLOBULIN
1mhp:X (GLN3) to (VAL116) CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY | INTEGRIN, CELL ADHESION, RECEPTOR, ANTIBODY, IMMUNE SYSTEM
4aei:I (VAL2) to (SER119) CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX | IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL
4p3d:A (VAL2) to (SER117) MT1-MMP:FAB COMPLEX (FORM II) | IMMUNE SYSTEM
5d70:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOR03929, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
5d72:M (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOR04252, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
3kr3:H (GLN3) to (VAL120) CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX | ANTIBODY-TARGET COMPLEX, CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, GLYCOPROTEIN, GROWTH FACTOR, HORMONE, MITOGEN, OSTEOGENESIS, SECRETED, IMMUNE SYSTEM
5d9q:D (VAL2) to (SER116) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:I (VAL2) to (SER116) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5d9q:O (VAL2) to (SER116) CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46 | HIV ENV GLYCOPROTEIN; BROADLY NEUTRALIZING ANTIBODIES; IMMUNE SYSTEM, IMMUNE SYSTEM
5dd3:H (GLN1) to (SER112) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
3kym:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:L (GLN3) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:N (GLN3) to (VAL117) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
4pfe:A (GLN231) to (SER344) CRYSTAL STRUCTURE OF VSFGFP-0 | BETA BARREL, FUSION PROTEIN, HOMODIMER, IMMUNE SYSTEM, FLUORESCENT PROTEIN
4pfe:B (GLN231) to (SER344) CRYSTAL STRUCTURE OF VSFGFP-0 | BETA BARREL, FUSION PROTEIN, HOMODIMER, IMMUNE SYSTEM, FLUORESCENT PROTEIN
4pgj:A (VAL2) to (SER120) HUMAN HEAVY-CHAIN DOMAIN ANTIBODY IN COMPLEX WITH HEN EGG-WHITE LYSOZYME | ANTIBODY HUMAN DAB CLEFT BINDER DAB-HEL COMPLEX, IMMUNE SYSTEM- HYDROLASE COMPLEX
3l1o:H (VAL2) to (SER121) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5dhx:B (GLU112) to (SER226) HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES | HIV, HELICAL HAIRPIN, RNA-BINDING, NUCLEAR EXPORT, IMMUNE SYSTEM
3l5w:H (VAL2) to (SER120) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l5w:B (GLN1) to (SER120) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
1yzz:B (VAL2) to (SER117) HUMANIZED CABAN33 AT ROOM TEMPERATURE | ANTIBODY, CAMEL ANTIBODY, HUMANIZATION, UNKNOWN FUNCTION
3l7e:H (VAL2) to (VAL119) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l7e:B (GLN1) to (SER120) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l95:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY | NRR, FAB FRAGMENT, ANTIBODY, ALPHA-BETA-SANDWICH, SEA DOMAIN, LNR, LIN12 NOTCH CYSTEINE-RICH, HD DOMAIN, CELL CYCLE, SIGNALING PROTEIN, ACTIVATOR, ANK REPEAT, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, METAL- BINDING, NOTCH SIGNALING PATHWAY, IMMUNE SYSTEM
4poy:A (GLN1) to (VAL119) ENGINEERED DUAL SPECIFIC VHH ANTIBODY | SINGLE DOMAIN ANTIBODY, VHH, METALLOREGULATION, BISPECIFIC, DUAL- FUNCTION, PROTEIN ENGINEERING, AFFINITY CONTROL, PROTEIN-SWITCH, ANTIBODY ENGINEERING, NICKEL BINDING PROTEIN, PROTEIN-METAL COORDINATION GEOMETRY, LOOP DYNAMICS, PROTEIN FLEXIBILITY, CONFORMATIONAL DYNAMICS, BINDING THERMODYNAMICS, ANTIBODY-METAL COMPLEX, IMMUNE SYSTEM
5do2:H (VAL2) to (VAL114) COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY | RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1zan:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
3liz:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3 | HYDROLASE-IMMUNE SYSTEM COMPLEX
1zlu:H (GLN3) to (SER112) FAB 2G12 + MAN5 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlu:M (GLN3) to (SER112) FAB 2G12 + MAN5 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlv:H (GLN3) to (SER112) FAB 2G12 + MAN7 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlv:M (GLN3) to (SER112) FAB 2G12 + MAN7 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlw:H (GLN3) to (SER112) FAB 2G12 + MAN8 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlw:M (GLN3) to (SER112) FAB 2G12 + MAN8 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
5e08:H (GLN4) to (VAL125) SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT | ANTIBODY, FAB, SSRNA, IMMUNE SYSTEM-RNA COMPLEX
5e0q:A (GLN3) to (VAL126) CRYSTAL STRUCTURE OF THE NUP98 C-TERMINAL DOMAIN BOUND TO NANOBODY TP377 | NUCLEAR PORE COMPLEX, NUCLEAR TRANSPORT, AUTOPROTEOLYTIC DOMAIN, ANTIBODY, TRANSPORT PROTEIN
3ls4:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC | IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX
3ls5:H (VAL2) to (SER116) ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM | IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX
1zvy:A (ASP1) to (VAL125) CRYSTAL STRUCTURE OF THE VHH D3-L11 IN COMPLEX WITH HEN EGG WHITE LYSOZYME | BETA SANDWICH, IMMUNOGLOBULIN FOLD, PROTEIN PROTEIN HETEROCOMPLEX, ALPHA-BETA ORTHOGONAL BUNDLE, HYDROLASE-IMMUNE SYSTEM COMPLEX
5e5m:F (VAL4) to (SER114) CRYSTAL STRUCTURE OF MOUSE CTLA-4 IN COMPLEX WITH NANOBODY | THE COMPLEX OF MOUSE CTLA-4 WITH ITS NANOBODY, TREATMENT OF METASTATIC MELANOMAS, IMMUNE SYSTEM
2a1w:I (VAL2) to (SER122) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I | IMMUNE SYSTEM
4q9q:H (GLN6) to (SER124) CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO BROMO-LIGAND ANALOG IN COMPLEX WITH FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE, RNA
4qci:B (GLN3) to (SER119) PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB | GROWTH FACTOR CYTOKINE FOLD, GROWTH FACTOR HORMONE, PDGFR-BETA RECEPTOR, EXTRACELLULAR, CYTOKINE-CYTOKINE RECEPTOR COMPLEX
4qci:H (GLN3) to (SER119) PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB | GROWTH FACTOR CYTOKINE FOLD, GROWTH FACTOR HORMONE, PDGFR-BETA RECEPTOR, EXTRACELLULAR, CYTOKINE-CYTOKINE RECEPTOR COMPLEX
4b50:A (GLU1) to (VAL111) CRYSTAL STRUCTURE OF THE HIV-1 GP41 MPER-SPECIFIC LLAMA VHH 2H10 | IMMUNE SYSTEM, NEUTRALIZING ANTIBODY
4qhk:O (VAL2) to (SER112) UCA (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhn:B (GLU3) to (VAL106) I2 (UNBOUND) FROM CH103 LINEAGE | FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM
4qhu:H (GLN3) to (SER114) CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX | ANTIBODY-ANTIGEN INTERACTION, RECEPTOR DIFFERENTIATION, MOLECULAR ASYMMETRY, CYSTINE KNOT, CYTOKINE IL-17, IL-17RA, IL-17RC, IMMUNE SYSTEM
4qhu:B (GLN3) to (SER114) CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX | ANTIBODY-ANTIGEN INTERACTION, RECEPTOR DIFFERENTIATION, MOLECULAR ASYMMETRY, CYSTINE KNOT, CYTOKINE IL-17, IL-17RA, IL-17RC, IMMUNE SYSTEM
5eii:A (VAL2) to (SER123) STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY | ANTIBODY, FAB, ASF1, STRUCTURAL GENOMICS, PSI-BIOLOGY, CHAPERONE- ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
5eii:H (VAL2) to (SER123) STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY | ANTIBODY, FAB, ASF1, STRUCTURAL GENOMICS, PSI-BIOLOGY, CHAPERONE- ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
3mbx:H (PCA1) to (VAL119) CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
2adg:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 | ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM
3mck:H (VAL2) to (SER122) CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3mck:B (VAL2) to (SER122) CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3b9v:D (GLN3) to (SER112) CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN | ANTIBODY ENGINEERING, PHAGE DISPLAY, IMMUNE SYSTEM
5eoq:H (VAL5) to (SER121) STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40 | ANTIBODY, FAB, VACCINIA VIRUS, NEUTRALIZING, LINEAR EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4bel:D (VAL161) to (SER270) BACE2 XAPERONE COMPLEX | HYDROLASE-IMMUNE SYSTEM COMPLEX, NANOBODY
3moa:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mob:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mod:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mug:L (GLU2) to (VAL111) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
3bn9:C (ASP1) to (ILE106) CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2 | ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE
3bn9:D (GLN3) to (SER112) CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2 | ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE
3bpc:B (VAL2) to (VAL109) CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-2,3-DEHYDRO KDO (4.8) KDO | FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
4qww:D (VAL2) to (SER124) CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX | A/B HYDROLASE FOLD, ACETYLCHOLINESTERASE, MONOCLONAL ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX
4qww:F (VAL2) to (SER124) CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX | A/B HYDROLASE FOLD, ACETYLCHOLINESTERASE, MONOCLONAL ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX
5f3h:A (LEU4) to (SER115) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3h:C (VAL2) to (SER115) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f97:E (VAL3) to (SER114) BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE | ADHESIN, LECTIN, NANOBODY, COMPLEX, CELL ADHESION
4r3s:A (GLN1) to (VAL112) CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 11-23 | IMMUNOGLOBULIN FOLD, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN, IMMUNE SYSTEM
5fgb:C (GLN3) to (THR119) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4 | FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, IMMUNE SYSTEM
5fgb:E (VAL2) to (VAL120) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4 | FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, IMMUNE SYSTEM
3c6s:F (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE | O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM
3c6s:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE | O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM
5fhx:H (GLN127) to (SER241) CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION. | CROSS-OVER DUAL VARIABLE IMMUNOGLOBULIN MULTIFUNCTIONAL BIOTHERAPEUTIC DRUG, CODV, IMMUNE SYSTEM
4r7d:I (GLN1) to (VAL116) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7d:M (GLN1) to (VAL116) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:E (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:K (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:O (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4rbp:H (GLN3) to (VAL111) CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE | IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM
4rbp:M (GLN3) to (SER112) CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE | IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM
3cfb:H (LYS3) to (VAL111) HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K | IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER
3cfb:B (LYS3) to (VAL111) HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K | IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER
3cfc:H (LYS3) to (VAL111) HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 | IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER
4rfe:C (GLN3) to (VAL111) CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB | HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM
4c83:A (VAL2) to (VAL111) CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS | IMMUNE SYSTEM, LIPOOLIGOSACCHARIDES, ANTIBODIES, ANTIGEN-ANTIBODY COMPLEX
4c83:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS | IMMUNE SYSTEM, LIPOOLIGOSACCHARIDES, ANTIBODIES, ANTIGEN-ANTIBODY COMPLEX
4rrp:G (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
4rrp:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
4rrp:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16 | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM
3csy:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3csy:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3csy:E (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3csy:G (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4rx4:A (GLN3) to (THR112) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3cxd:H (VAL2) to (SER115) CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE | FAB, OSTEOPONTIN, OPN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
3o41:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3o41:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3o45:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3o45:A (GLN1) to (SER112) CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3d0v:B (ARG1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW | 2F5, HIV, GP41, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
4s2s:H (VAL2) to (VAL117) CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
4s2s:A (VAL2) to (VAL117) CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
3oau:H (VAL2) to (SER122) ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON- DOMAIN-EXCHANGED FORMS, BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED | FAB, IMMUNE SYSTEM
3oaz:H (GLN3) to (SER112) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3oaz:M (GLN3) to (SER112) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3ob0:H (GLN3) to (SER112) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3ob0:M (GLN3) to (VAL111) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3d69:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12 | ANTICOAGULANT, 10C12, FACTOR IX, GLA DOMAIN, IMMUNE SYSTEM
3d69:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12 | ANTICOAGULANT, 10C12, FACTOR IX, GLA DOMAIN, IMMUNE SYSTEM
5ggu:A (VAL2) to (VAL123) CRYSTAL STRUCTURE OF TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggv:H (VAL2) to (VAL123) CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
4tsa:H (VAL2) to (SER112) STRUCTURE OF A LYSOZYME FAB COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
4tsb:H (VAL2) to (SER112) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
3oke:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
3okk:B (VAL2) to (VAL120) CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
3okl:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
3okn:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO | ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM
4d3c:H (GLN3) to (VAL114) CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68. | PROTEIN BINDING
5gs3:H (VAL2) to (VAL117) CRYSTAL STRUCTURE OF DIABODY | DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM
5gs3:A (VAL2) to (VAL117) CRYSTAL STRUCTURE OF DIABODY | DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM
3drq:B (ARG1) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION | HIV-1, 2F5, GP41, NMAB, IMMUNE SYSTEM
3drt:B (ARG1) to (ILE111) CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 | HIV-1, GP41, 2F5, NMAB, IMMUNE SYSTEM
4u1g:B (GLN3) to (VAL120) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
4u1g:E (GLN3) to (VAL120) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
3dsf:H (VAL2) to (SER115) CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE | FAB, OSTEOPONTIN, OPN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4dag:H (GLN3) to (SER121) STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE | VIRAL PROTEIN, MPV FUSION PROTEIN, ANTIBODY, IMMUNE SYSTEM, DS7 ANTIBODY STRUCTURE, DS7, FAB STRUCTURE, VACCINE, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
3dvg:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI- UBIQUITIN | DI-UBIQUITIN, FAB FRAGMENT, ANTIBODY, NUCLEUS, PHOSPHOPROTEIN, RIBOSOMAL PROTEIN, IMMUNE SYSTEM
5hcg:H (VAL126) to (SER241) CRYSTAL STRUCTURE OF FREE-CODV. | CROSS-OVER DUAL VARIABLE IMMUNOGLOBIN, MULTIFUNCTIONAL BIOTHERAPEUTIC FORMAT, BISPECIFIC PROPERTY, CODV, IMMUNE SYSTEM
3dwt:A (GLN3) to (SER127) STRUCTURE OF CABBCII-10 NANOBODY | NANOBODY, HUMANIZATION, ANTIBODY, DROMEDARY VH DOMAIN, VHH DOMAIN, IMMUNE SYSTEM
4dgy:H (VAL2) to (SER112) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, C2 FORM | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
5hi3:C (VAL2) to (SER112) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi3:H (VAL2) to (SER112) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi4:C (VAL2) to (SER112) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi4:H (VAL2) to (SER112) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
5hi5:H (VAL2) to (SER112) BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS | IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX
3p11:H (GLN3) to (SER112) ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION | BETA-SANDWICH, ANTIGENS HER3, IMMUNE SYSTEM
4u6v:K (GLN3) to (SER121) MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY | ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM
4dkf:I (GLN3) to (VAL111) CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2 | DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX
4uao:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY | MALARIA, CELL INVASION, INVASION INHIBITORY ANTIBODY
4ub0:H (VAL2) to (SER119) NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE | FAB, KNOBS-INTO-HOLES, BISPECIFIC, IMMUNE SYSTEM
5hvf:B (GLN3) to (SER118) CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-I83) | PROCARBOXYPEPTIDASE U, THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR, TAFI, PROCARBOXYPEPTIDASE R, PLASMA PROCARBOXYPEPTIDASE B, NANOBODY, ANTIBODY FRAGMENT, PROTEIN COMPLEX, HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5hvh:B (GLN3) to (VAL120) CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH TWO INHIBITORY NANOBODIES | PROCARBOXYPEPTIDASE U, THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR, TAFI, PROCARBOXYPEPTIDASE R, PLASMA PROCARBOXYPEPTIDASE B, NANOBODY, ANTIBODY FRAGMENT, PROTEIN COMPLEX, HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5i15:H (VAL2) to (VAL117) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i19:H (GLN3) to (VAL117) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1c:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-20 | IMMUNE SYSTEM
5i1d:H (VAL2) to (VAL117) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1g:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4dw2:H (VAL2) to (SER112) THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112 | UROKINASE-TYPE PLASMINOGEN ACTIVATOR, ANTIBODY, SERINE PROTEASE, ZYMOGEN, HYDROLASE-IMMUNE SYSTEM COMPLEX
3pjs:B (GLN3) to (SER123) MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL | ION CHANNEL, CONDUCTS K+ IONS, CELL MEMBRANE, TRANSPORT PROTEIN
3pnw:K (VAL5) to (SER128) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
3pnw:W (VAL5) to (SER128) CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB | FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX
4uu9:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE HUMAN C5A IN COMPLEX WITH MEDI7814 A NEUTRALISING ANTIBODY | IMMUNE SYSTEM, FV, COMPLEMENT SYSTEM
4ej1:C (GLN3) to (SER127) BINDING OF NB113 CAMELID ANTIBODY FRAGMENT WITH THE BINARY DHFR:FOLATE COMPLEX | FOLATE, OXIDOREDUCTASE-IMMUNE SYSTEM COMPLEX
5ip4:A (GLN5) to (SER112) X-RAY STRUCTURE OF THE C-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN | DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE
3qct:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
3qcv:H (GLU1) to (SER112) CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2) | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
3qcv:I (GLU1) to (SER112) CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2) | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
4f58:H (VAL2) to (VAL111) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
4f58:I (VAL2) to (VAL111) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
4f58:J (VAL2) to (VAL111) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
4f58:K (VAL2) to (VAL111) FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT | IG, ANTIBODY, GP120, IMMUNE SYSTEM
3qhf:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB DEL2D1, A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, INFLUENZA A VIRUS HEMAGGLUTININ, EXTRACELLULAR (SECRETED), IMMUNE SYSTEM
3qny:D (LEU4) to (VAL117) MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3qpx:H (GLN3) to (VAL117) CRYSTAL STRUCTURE OF FAB C2507 | IMMUNOGLOBULIN, IMMUNE SYSTEM, MOUSE IL-17A
3qwo:H (GLN1) to (VAL111) CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB | IMMUNE COMPLEX, IMMUNE SYSTEM
3qwo:A (GLN1) to (VAL111) CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB | IMMUNE COMPLEX, IMMUNE SYSTEM
3qyc:A (VAL4) to (VAL125) STRUCTURE OF A DIMERIC ANTI-HER2 SINGLE DOMAIN ANTIBODY | IMMUNOGLOBULIN V DOMAIN FOLD, ANTIBODY, IMMUNE SYSTEM
3r08:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOUSE CD3EPSILON IN COMPLEX WITH ANTIBODY 2C11 FAB | CD3EPSILON, ANTIBODY, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3r0m:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12 | IG DOMAIN, IMMUNE SYSTEM
4fqh:A (GLN1) to (SER112) CRYSTAL STRUCTURE OF FAB CR9114 | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM
5jqh:D (GLN1) to (VAL117) STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO CARAZOLOL AND INACTIVE-STATE STABILIZING NANOBODY, NB60 | GPCR, SIGNALING, NANOBODY, ALLOSTERY, SIGNALING PROTEIN, HYDROLASE, HYDROLASE-INHIBITOR COMPLEX
5jqh:C (GLN1) to (VAL117) STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO CARAZOLOL AND INACTIVE-STATE STABILIZING NANOBODY, NB60 | GPCR, SIGNALING, NANOBODY, ALLOSTERY, SIGNALING PROTEIN, HYDROLASE, HYDROLASE-INHIBITOR COMPLEX
4fz8:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY. | ADCC, ANTI-HIV-1 ENV ANTIBODY C11, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
5jw4:M (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jw4:O (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jw4:Q (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jw4:S (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jw4:U (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jw4:W (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA | ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM
5jw5:H (GLN1) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT | ANTIBODY INFLUENZA, IMMUNE SYSTEM
5jw5:A (VAL2) to (THR125) STRUCTURE OF MEDI8852 FAB FRAGMENT | ANTIBODY INFLUENZA, IMMUNE SYSTEM
4g5z:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF THE THERAPEUTICAL ANTIBODY FRAGMENT OF CANAKINUMAB IN ITS UNBOUND STATE | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNOGLOBULIN, INTERLEUKINE-1BETA BINDING, CYTOKINE, BLOOD SYSTEM, IMMUNE SYSTEM
4gg8:B (GLY3) to (GLU116) IMMUNE RECEPTOR | IMMUNE RECEPTOR, IMMUNE SYSTEM
2ai0:J (VAL2) to (SER122) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III | IMMUNE SYSTEM
2ai0:K (VAL2) to (SER122) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III | IMMUNE SYSTEM
3egs:B (ARG1) to (SER132) CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 SOAKED IN AMMONIUM SULFATE | 2F5, GP41, HIV, IMMUNE SYSTEM
1aj7:H (GLN3) to (SER112) IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY | GERMLINE ANTIBODY, FAB, CATALYTIC ANTIBODY, AFFINITY MATURATION, IMMUNOGLOBULIN
1bm3:H (VAL2) to (SER124) IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX | IMMUNOGLOBULIN, IMMUNE SYSTEM
1bvl:C (VAL2) to (THR113) HUMANIZED ANTI-LYSOZYME FV | HUMANIZED ANTIBODY, FV, ANTI-LYSOZYME
4xh2:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xh2:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xh2:G (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xh2:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
4xh2:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT | SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION
3sge:H (VAL2) to (SER114) CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE | IMMUNOGLOBULIN, ANTIGEN BINDING, IMMUNE SYSTEM
3sge:J (VAL2) to (SER114) CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE | IMMUNOGLOBULIN, ANTIGEN BINDING, IMMUNE SYSTEM
1ol0:B (VAL2) to (SER120) CRYSTAL STRUCTURE OF A CAMELISED HUMAN VH | IMMUNOGLOBULIN, CAMELISED VARIABLE HEAVY DOMAIN
1cic:D (VAL2) to (VAL114) IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225 | IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE
3sob:H (VAL2) to (VAL111) THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB | BETA PROPELLER, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4idl:A (LYS1) to (SER122) LOW MELTING TEMPERATURE ANTI-CHOLERA TOXIN LLAMA VHH DOMAIN | V-TYPE IMMUNOGLOBIN FOLD, ANTIBODY, CHOLERA TOXIN, IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY
1p84:J (GLU1) to (THR119) HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX | CYTOCHROME BC1 COMPLEX, COMPLEX III, UBIQUINOL, CYTOCHROME C OXIDOREDUCTASE, HYDROXYQUINONE, HHDBT, QO SITE, PHOSPHOLIPID, MEMBRANE PROTEIN
3t65:B (VAL2) to (VAL109) S25-2- A(2-8)KDO DISACCHARIDE COMPLEX | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM
3gjf:H (VAL2) to (VAL117) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
3gjf:M (VAL2) to (SER118) RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES | MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM
4y5v:A (VAL2) to (SER117) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4y5v:D (VAL2) to (VAL116) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4y5v:G (VAL2) to (SER117) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4y5x:G (VAL2) to (SER123) DIABODY 305 COMPLEX WITH EPOR | DIABODY COMPLEX, RECEPTOR
4y7m:A (VAL2) to (VAL127) T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC | TYPE 6 SECRETION SYSTEM, ALPHA-BETA FOLD, PERIPLASMIC PROTEIN, MEMBRANE PROTEIN
4y7m:B (VAL2) to (SER128) T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC | TYPE 6 SECRETION SYSTEM, ALPHA-BETA FOLD, PERIPLASMIC PROTEIN, MEMBRANE PROTEIN
4yny:A (VAL21) to (VAL134) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4yny:C (VAL21) to (SER135) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4yo0:C (VAL21) to (SER135) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PEPTIDES, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
4yue:H (GLU4) to (VAL124) MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT | CHEMOKINE, ANTIBODY, COMPLEX, CYTOKINE/IMMUNE SYSTEM COMPLEX
1fve:B (VAL2) to (SER119) X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING | IMMUNOGLOBULIN
1fve:D (GLN3) to (SER119) X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING | IMMUNOGLOBULIN
1rzj:H (GLU1) to (SER112) HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB); HIV-1 EXTERIOR ENVELOPE GP120 FROM LABORATORY-ADAPTED ISOLATE; HXBC2; SURFACE T-CELL GLYCOPROTEIN CD4; ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4kze:H (GLN6) to (SER124) CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE BINDING, IMMUNE SYSTEM-RNA COMPLEX
4zpt:A (VAL2) to (VAL111) STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1) | VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1tji:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE | 2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
4zyp:N (GLN1) to (VAL111) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
4llu:C (VAL2) to (SER112) STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A | FAB, IMMUNE SYSTEM
2hwz:H (VAL2) to (VAL111) FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM) | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM
1u92:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC) | FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM
1ikf:H (VAL2) to (SER125) A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX | IMMUNE SYSTEM-IMMUNOSUPPRESSANT COMPLEX, FAB-CYCLOSPORIN COMPLEX, CYCLOSPORIN A, IMMUNOSUPPRESSANT
2xa3:A (ALA1) to (SER112) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING LLAMA VHH D7 AND ITS MODE OF HIV-1 GP120 INTERACTION | IMMUNE SYSTEM
4nby:B (GLN10) to (SER129) CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO TWO MOLECULES OF A20.1 VHH | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4nby:C (GLN10) to (SER129) CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO TWO MOLECULES OF A20.1 VHH | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4nc1:D (GLN10) to (SER129) CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A20.1 VHH AND A26.8 VHH | ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
3zlq:C (GLN160) to (SER270) BACE2 XAPERONE COMPLEX | HYDROLASE-IMMUNE SYSTEM COMPLEX
5c7x:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
4nzu:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT | ANTIBODY FAB, MULTIPLE MYELOMA, PRIMARY ANTIBODY, IMMUNE SYSTEM
1l7i:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4 | IG DOMAIN, FAB FRAGMENT, IMMUNE SYSTEM
2nxy:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3k74:B (GLN162) to (VAL274) DISRUPTION OF PROTEIN DYNAMICS BY AN ALLOSTERIC EFFECTOR ANTIBODY | IMMUNOGLOBULIN, PROTEIN-NANOBODY COMPLEX, ANTIBIOTIC RESISTANCE, METHOTREXATE RESISTANCE, NADP, ONE-CARBON METABOLISM, OXIDOREDUCTASE, TRIMETHOPRIM RESISTANCE
3ks0:H (GLU1) to (SER116) CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4 | ELECTRON TRANSFER, EPITOPE, DOMAIN MOBILITY, FLAVOCYTOCHROME B2, ANTIBODY, FAB, HEME DOMAIN, ELECTRON TRANSPORT, FLAVOPROTEIN, FMN, HEME, METAL-BINDING, MITOCHONDRION, OXIDOREDUCTASE, RESPIRATORY CHAIN, TRANSIT PEPTIDE, TRANSPORT
3ks0:K (GLN3) to (SER116) CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4 | ELECTRON TRANSFER, EPITOPE, DOMAIN MOBILITY, FLAVOCYTOCHROME B2, ANTIBODY, FAB, HEME DOMAIN, ELECTRON TRANSPORT, FLAVOPROTEIN, FMN, HEME, METAL-BINDING, MITOCHONDRION, OXIDOREDUCTASE, RESPIRATORY CHAIN, TRANSIT PEPTIDE, TRANSPORT
4pir:J (ASP1) to (SER123) X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR | MEMBRANE TRANSPORT, ION CHANNEL, TRANSPORT PROTEIN
3lev:H (ILE2) to (SER112) HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2 | HIV-1, GP41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, SIGMA FACTOR, RE-ELICITATION, IMMUNE SYSTEM, VACCINE DESIGN
1za3:A (ASP1) to (ILE105) THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5 | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
1za3:B (GLN3) to (VAL111) THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5 | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
1za3:H (GLN3) to (SER112) THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5 | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
1zls:H (GLN3) to (SER112) FAB 2G12 + MAN4 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN-SWAPPING, IMMUNE SYSTEM
4q9r:H (GLN6) to (SER124) CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO TRIFLUOROETHYL-LIGAND ANALOG IN COMPLEX WITH FAB | G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE, RNA-IMMUNE SYSTEM COMPLEX
2agj:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY | ANTIBODY, IMMUNOGLOBULIN SUPERFAMILY, CATALYTIC ANTIBODY, IMMUNE SYSTEM
3cfe:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10 | IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM
3cfe:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10 | IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM
3nzh:H (MET3) to (VAL115) CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4rwy:H (GLN3) to (THR112) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC131 IN COMPLEX WITH HIV-1 CLADE B YU2 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY 8ANC131, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3o6k:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1 | ANTIGEN-BINDING SITE, U-SHAPED GROOVE, IMMUNE SYSTEM, TAT HIV
4tsc:H (VAL2) to (VAL111) STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX
4d9l:I (GLN1) to (SER112) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4d9l:J (GLN1) to (VAL111) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4d9l:K (GLN1) to (SER112) FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
5hgg:S (GLN3) to (VAL125) CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH A CAMELID-DERIVED ANTIBODY FRAGMENT | UPA, NANOBODY, SERINE PROTEASE, HYDROLASE-INHIBITOR COMPLEX
5hvg:B (GLN3) to (VAL120) CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-A204) | PROCARBOXYPEPTIDASE U, THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR, TAFI, PROCARBOXYPEPTIDASE R, PLASMA PROCARBOXYPEPTIDASE B, NANOBODY, ANTIBODY FRAGMENT, PROTEIN COMPLEX, HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3piq:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
3piq:E (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
5iq9:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE. | IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM
3qcu:I (GLU1) to (SER112) CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0) | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
3qq9:D (VAL2) to (SER119) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F | IMMUNE SYSTEM, RSV F PROTEIN
3r06:B (VAL2) to (VAL111) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3r06:D (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3r06:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
4fqq:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
4fqq:F (GLN3) to (SER112) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM